Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy

Neurol Sci. 2024 Aug;45(8):4107. doi: 10.1007/s10072-024-07510-y.

Umberto Pensato^{1

2}, Federica Pondrelli^{3

4}, Chiara de Philippis⁵, Gian Maria Asioli^{3

4}, Alessandra Crespi^{6

7}, Alessandro Buizza^{6

7}, Daniele Mannina⁵, Beatrice Casadei⁸, Enrico Maffini⁸, Laura Straffi⁷, Simona Marcheselli⁷, Pier Luigi Zinzani^{8

9}, Francesca Bonifazi⁸, Maria Guarino⁴, Stefania Bramanti⁵

¹ Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy. umbertopensato91@gmail.com.
² IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy. umbertopensato91@gmail.com.
³ Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
⁴ IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
⁵ BMT and Cell Therapy Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
⁶ Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.
⁷ IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
⁸ IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia "Seràgnoli", Bologna, Italy.
⁹ Dipartimento Di Scienze Mediche E Chirurgiche, Università Di Bologna, Bologna, Italy.

No abstract available

Publication types